TRANSFORMING CANCER TREATMENT THROUGH PRECISION MEDICINE
Tracks
SEVERO OCHOA ROOM
| Wednesday, October 8, 2025 |
| 16:00 - 16:45 |
| SEVERO OCHOA ROOM |
Overview
Sponsor: BMS
Details
Precision medicine enables tailored treatments for cancer by analyzing a patient's individual genetic and molecular characteristics, along with their tumor's specific profile, to identify the most effective, targeted therapies. Key steps include molecular profiling to identify genetic mutations or biomarkers, which then guides the selection of targeted drugs or helps in the early detection and prevention of cancer. Precision medicine should lead to increased Treatment Efficacy, reduced side effects and improved prognosis.
This round table will examine recent developments and identify challenges to adoption and market access.
Details
Ms Belén Marzo Spinola
Head Of Health
FI Group
Moderator
Bristol Myers Squibb
BMS
Sponsor
Carmen Garrido
Disease Área Specialist Spain & Portugal Medical Affairs
Bristol Myers Squibb
Speaker
Ms Olivia McDermid
International Oncology Health Policy Director
Amgen (on behalf of EFPIA)
Speaker
Dr José Leal
CEO
Ophiomics
Speaker
Mr Michael R. Green
President and CEO
Canada Health Infoway
Speaker
